SEMAGLUTIDE (GLP-1) 10MG Type 2 Diabetes Treatment and Long-Term Weight Management

Type 2 Diabetes Treatment and Long-Term Weight Management Semaglutide is a glucagon-like peptide 1 receptor agonist that helps lower blood sugar levels by increasing insulin production. Semaglutide works by stimulating the growth of pancreatic beta cells, which help synthesize and secrete insulin and inhibit the production of glucagon, a hormone that increases blood sugar. The peptide also helps reduce body fat by slowing digestion and suppressing one’s appetite. Initially approved by the FDA for type 2 diabetes in injectable form in 2017 and as an oral medication in 2019, the FDA expanded its approval as an adjunct to diet and exercise for long-term weight management in 2021. Semaglutide is prescribed for chronic weight loss to patients with a body mass index of 30 or greater (clinically obese) and to anyone considered overweight who has a weight-related condition, such as type 2 diabetes, high blood pressure or high cholesterol. In a 68-week double-blind trial of nearly 2,000 obese